Philips and Glygenix Therapeutics Partner on Ultrasound Research

by Barbara Kram, Editor | August 05, 2009

About GlyGenix Therapeutics

Based in Woodbridge, CT, GlyGenix Therapeutics, Inc. is a privately held biotech company developing therapeutic solutions for severe metabolic disorders. The company's initial focus is in using gene therapy products with non-viral delivery systems for the treatment of Glycogen Storage Disease Type 1a (GSD1a), a rare and severe chronic genetic liver disease for which no approved therapies exist. Founded in 2006, and with the aid of a sizable body of pre-clinical data, GlyGenix Therapeutics, Inc is poised to expedite the initiation of clinical trials for the treatment of GSD1a. News from GlyGenix Therapeutics, Inc is located at www.glygenixtherapeutics.com.

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money